BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27580103)

  • 1. Concentrations of tilmicosin in mammary gland secretions of dairy cows following subcutaneous administration of one or two doses of an experimental preparation of tilmicosin and its efficacy against intramammary infections caused by Staphylococcus aureus.
    Mendoza J; Martínez-Cortés I; López-Ordaz R; Gutiérrez L; Sumano H
    Am J Vet Res; 2016 Sep; 77(9):922-30. PubMed ID: 27580103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off.
    Nickerson SC; Owens WE; Fox LK; Scheifinger CC; Shryock TR; Spike TE
    J Dairy Sci; 1999 Apr; 82(4):696-703. PubMed ID: 10212455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period.
    Dingwell RT; Leslie KE; Duffield TF; Schukken YH; DesCoteaux L; Keefe GP; Kelton DF; Lissemore KD; Shewfelt W; Dick P; Bagg R
    J Dairy Sci; 2003 Jan; 86(1):159-68. PubMed ID: 12613861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation.
    Owens WE; Nickerson SC; Ray CH
    J Dairy Sci; 1999 Mar; 82(3):645-7. PubMed ID: 10194686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination kinetics of tilmicosin following intramammary administration in lactating dairy cattle.
    Smith GW; Davis JL; Baynes RE; Yeatts JL; Barlow BM; Riviere JE
    J Am Vet Med Assoc; 2009 Jan; 234(2):245-8. PubMed ID: 19210246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of intramammary tilmicosin at drying-off, and other risk factors for the prevention of new intramammary infections during the dry period.
    Dingwell RT; Duffield TF; Leslie KE; Keefe GP; DesCoteaux L; Kelton DF; Lissemore KD; Schukken YH; Dick P; Bagg R
    J Dairy Sci; 2002 Dec; 85(12):3250-9. PubMed ID: 12512598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negatively controlled, randomized clinical trial to evaluate intramammary treatment of nonsevere, gram-negative clinical mastitis.
    Fuenzalida MJ; Ruegg PL
    J Dairy Sci; 2019 Jun; 102(6):5438-5457. PubMed ID: 30981475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-inferiority study evaluating a new extended-release preparation of tilmicosin injected subcutaneously vs. ceftiofur administered intramammary, as dry-cow therapy in Holstein Friesian cows.
    Ortega E; Alfonseca-Silva E; Posadas E; Tapia G; Sumano H
    J Vet Sci; 2020 Nov; 21(6):e87. PubMed ID: 33263234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity of macrophages against Streptococcus uberis is different in mammary gland secretions of lactating and drying off cows.
    Denis M; Parlane NA; Lacy-Hulbert SJ; Summers EL; Buddle BM; Wedlock DN
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):111-20. PubMed ID: 16949677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of milk and mammary tissue concentrations of ceftiofur after intramammary and intramuscular therapy.
    Owens WE; Xiang ZY; Ray CH; Nickerson SC
    J Dairy Sci; 1990 Dec; 73(12):3449-56. PubMed ID: 2099366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intramammary tilmicosin infusion as a dry cow therapy.
    Mohammadsadegh M
    J Vet Pharmacol Ther; 2018 Feb; 41(1):22-27. PubMed ID: 28600854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramammary infection rate during the dry period in cows that received blanket dry cow therapy: efficacy of 6 different dry-cow intra-mammary antimicrobial products.
    Petzer IM; Lourens DC; van der Schans TJ; Watermeyer JC; van Reenen R; Rautenbach GH; Thompson P
    J S Afr Vet Assoc; 2009 Mar; 80(1):23-30. PubMed ID: 19653515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows.
    Oliver SP; Gillespie BE; Headrick SJ; Moorehead H; Lunn P; Dowlen HH; Johnson DL; Lamar KC; Chester ST; Moseley WM
    J Dairy Sci; 2004 Aug; 87(8):2393-400. PubMed ID: 15328260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination kinetics of ceftiofur hydrochloride after intramammary administration in lactating dairy cows.
    Smith GW; Gehring R; Riviere JE; Yeatts JL; Baynes RE
    J Am Vet Med Assoc; 2004 Jun; 224(11):1827-30. PubMed ID: 15198270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows.
    Gillespie BE; Moorehead H; Lunn P; Dowlen HH; Johnson DL; Lamar KC; Lewis MJ; Ivey SJ; Hallberg JW; Chester ST; Oliver SP
    Vet Ther; 2002; 3(4):373-80. PubMed ID: 12584673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for isolation of Staphylococcus aureus or Streptococcus dysgalactiae from milk culture obtained approximately 6 days post calving.
    Osterås O; Whist AC; Sølverød L
    J Dairy Res; 2008 Feb; 75(1):98-106. PubMed ID: 18226294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical note: Therapeutic cessation of lactation of Staphylococcus aureus-infected mammary quarters.
    Middleton JR; Fox LK
    J Dairy Sci; 2001 Sep; 84(9):1976-8. PubMed ID: 11573776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of milk yield and infection status at dry-off with intramammary infections at subsequent calving.
    Newman KA; Rajala-Schultz PJ; Degraves FJ; Lakritz J
    J Dairy Res; 2010 Feb; 77(1):99-106. PubMed ID: 19906321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tilmicosin modulates the innate immune response and preserves casein production in bovine mammary alveolar cells during Staphylococcus aureus infection.
    Martínez-Cortés I; Acevedo-Domínguez NA; Olguin-Alor R; Cortés-Hernández A; Álvarez-Jiménez V; Campillo-Navarro M; Sumano-López HS; Gutiérrez-Olvera L; Martínez-Gómez D; Maravillas-Montero JL; Loor JJ; García-Zepeda EA; Soldevila G
    J Anim Sci; 2019 Feb; 97(2):644-656. PubMed ID: 30517644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a lysostaphin-fusion protein as a dry-cow therapy for Staphylococcus aureus mastitis in dairy cattle.
    Hoernig KJ; Donovan DM; Pithua P; Williams F; Middleton JR
    J Dairy Sci; 2016 Jun; 99(6):4638-4646. PubMed ID: 27040789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.